ImmuCell Revenue 2006-2020 | ICCC
ImmuCell revenue from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| ImmuCell Annual Revenue (Millions of US $) |
|
|---|---|
| 2019 | $14 |
| 2018 | $11 |
| 2017 | $10 |
| 2016 | $10 |
| 2015 | $10 |
| 2014 | $8 |
| 2013 | $6 |
| 2012 | $5 |
| 2011 | $5 |
| 2010 | $4 |
| 2009 | $5 |
| 2008 | $5 |
| 2007 | $6 |
| 2006 | $5 |
| 2005 | $5 |
| ImmuCell Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2020-03-31 | $5 |
| 2019-12-31 | $4 |
| 2019-09-30 | $3 |
| 2019-06-30 | $3 |
| 2019-03-31 | $4 |
| 2018-12-31 | $3 |
| 2018-09-30 | $2 |
| 2018-06-30 | $3 |
| 2018-03-31 | $3 |
| 2017-12-31 | $3 |
| 2017-09-30 | $2 |
| 2017-06-30 | $2 |
| 2017-03-31 | $4 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $3 |
| 2015-12-31 | $3 |
| 2015-09-30 | $2 |
| 2015-06-30 | $2 |
| 2015-03-31 | $3 |
| 2014-12-31 | $2 |
| 2014-09-30 | $2 |
| 2014-06-30 | $2 |
| 2014-03-31 | $2 |
| 2013-12-31 | $2 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $2 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $2 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $2 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| 2008-12-31 | $1 |
| 2008-09-30 | $1 |
| 2008-06-30 | $1 |
| 2008-03-31 | $2 |
| 2007-12-31 | $2 |
| 2007-09-30 | $2 |
| 2007-06-30 | $1 |
| 2007-03-31 | $2 |
| 2006-12-31 | $1 |
| 2006-09-30 | $1 |
| 2006-06-30 | $1 |
| 2006-03-31 | $2 |
| 2005-12-31 | $1 |
| 2005-09-30 | $1 |
| 2005-06-30 | $1 |
| 2005-03-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.040B | $0.014B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $165.688B | 28.73 |
| Medtronic (MDT) | Ireland | $120.891B | 19.64 |
| Stryker (SYK) | United States | $66.633B | 21.63 |
| Boston Scientific (BSX) | United States | $48.278B | 22.70 |
| Baxter (BAX) | United States | $43.462B | 26.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.008B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.981B | 0.00 |
| Terumo (TRUMY) | Japan | $28.231B | 36.09 |
| ResMed (RMD) | United States | $28.021B | 44.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.281B | 15.28 |
| Sunny Optical Technology (SNPTF) | China | $20.840B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.828B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.172B | 64.51 |
| Insulet (PODD) | United States | $13.329B | 1320.56 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| Quidel (QDEL) | United States | $10.288B | 80.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $8.773B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.676B | 39.13 |
| Perrigo (PRGO) | Ireland | $7.396B | 13.23 |
| Hill-Rom Holdings (HRC) | United States | $7.394B | 20.84 |
| William Demant Holdings (WILYY) | Denmark | $6.296B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.620B | 0.00 |
| Haemonetics (HAE) | United States | $4.381B | 26.31 |
| Neogen (NEOG) | United States | $4.079B | 69.10 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.977B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.923B | 0.00 |
| ICU Medical (ICUI) | United States | $3.761B | 27.44 |
| Agios Pharmaceuticals (AGIO) | United States | $3.676B | 0.00 |
| Envista Holdings (NVST) | United States | $3.138B | 0.00 |
| NuVasive (NUVA) | United States | $2.743B | 22.03 |
| TG Therapeutics (TGTX) | United States | $2.661B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.237B | 38.71 |
| AtriCure (ATRC) | United States | $1.768B | 0.00 |
| MacroGenics (MGNX) | United States | $1.508B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.361B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.333B | 0.00 |
| Aphria (APHA) | Canada | $1.206B | 0.00 |
| Cerus (CERS) | United States | $1.148B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.069B | 40.24 |
| Cardiovascular Systems (CSII) | United States | $1.042B | 0.00 |
| Vapotherm (VAPO) | United States | $1.014B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 19.85 |
| PetIQ (PETQ) | United States | $0.961B | 27.75 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.890B | 148.08 |
| OraSure Technologies (OSUR) | United States | $0.860B | 173.13 |
| Zynex (ZYXI) | United States | $0.853B | 85.70 |
| InMode (INMD) | Israel | $0.853B | 18.02 |
| Quanterix (QTRX) | United States | $0.779B | 0.00 |
| Omeros (OMER) | United States | $0.731B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.646B | 46.29 |
| BioLife Solutions (BLFS) | United States | $0.572B | 162.82 |
| VAREX IMAGING (VREX) | United States | $0.571B | 14.18 |
| Lantheus Holdings (LNTH) | United States | $0.571B | 11.49 |
| Surmodics (SRDX) | United States | $0.562B | 67.75 |
| LeMaitre Vascular (LMAT) | United States | $0.521B | 29.67 |
| Owens & Minor (OMI) | United States | $0.466B | 12.33 |
| Viemed Healthcare (VMD) | United States | $0.413B | 36.62 |
| Cytosorbents (CTSO) | United States | $0.368B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.343B | 0.00 |
| HEXO (HEXO) | $0.328B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.302B | 21.90 |
| Organigram Holdings (OGI) | Canada | $0.262B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.224B | 124.11 |
| Female Health (VERU) | United States | $0.209B | 0.00 |
| Chimerix (CMRX) | United States | $0.192B | 0.00 |
| Surface Oncology (SURF) | United States | $0.161B | 0.00 |
| Bovie Medical (APYX) | United States | $0.158B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 11.83 |
| Exagen (XGN) | United States | $0.133B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.122B | 0.00 |
| United Health Products (UEEC) | United States | $0.117B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.114B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.108B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.104B | 0.00 |
| Evolus (EOLS) | United States | $0.102B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.096B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Nephros (NEPH) | United States | $0.068B | 0.00 |
| United-Guardian (UG) | United States | $0.066B | 15.32 |
| Capricor Therapeutics (CAPR) | United States | $0.065B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.063B | 0.00 |
| Brainsway (BWAY) | Israel | $0.060B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
